Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 21, 2021 - Issue 5
Submit an article Journal homepage
2,087
Views
10
CrossRef citations to date
0
Altmetric
Original research

Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia

Meredith E. Mowitza Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USACorrespondence[email protected]
View further author information
,
Alexandra Mangilib Global Clinical Development, Rare Metabolic Diseases, Shire, A Takeda Company, Zurich, SwitzerlandView further author information
,
Linda Hanc Global Clinical Development, Rare Metabolic Diseases, Shire, A Takeda Company, Lexington, MA, USAView further author information
,
Rajeev Ayyagarid Analysis Group Inc., Boston, MA, USAView further author information
,
Wei Gaod Analysis Group Inc., Boston, MA, USAView further author information
,
Jessie Wangd Analysis Group Inc., Boston, MA, USAView further author information
,
Jing Zhaod Analysis Group Inc., Boston, MA, USAView further author information
&
Sujata P. Sardae Global Evidence and Outcomes, Shire, A Takeda Company, Lexington, MA, USAView further author information
 show all
Pages 1117-1125 | Received 10 Feb 2020, Accepted 05 Nov 2020, Published online: 04 Dec 2020

References

  • Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
  • Keller RL, Feng R, DeMauro SB, et al. Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study. J Pediatr. 2017;187:89–97.
  • Islam JY, Keller RL, Aschner JL, et al. Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;192(2):134–156.
  • Jobe AH. Mechanisms of lung injury and bronchopulmonary dysplasia. Am J Perinatol. 2016;33(11):1076–1078.
  • Berkelhamer SK, Mestan KK, Steinhorn RH. Pulmonary hypertension in bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):124–131.
  • Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):145–157.
  • Ali K, Greenough A. Long-term respiratory outcome of babies born prematurely. Ther Adv Respir Dis. 2012;6(2):115–120.
  • Bhandari A, McGrath-Morrow S. Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):132–137.
  • Davidson LM, Berkelhamer SK. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med. 2017;6(1):4.
  • Johnson TJ, Patel AL, Jegier BJ, et al. Cost of morbidities in very low birth weight infants. J Pediatr. 2013;162(2):243–249.
  • Landry JS, Croitoru D, Jin Y, et al. Health care utilization by preterm infants with respiratory complications in Quebec. Can Respir J. 2012;19(4):255–260.
  • Morrow CB, McGrath-Morrow SA, Collaco JM. Predictors of length of stay for initial hospitalization in infants with bronchopulmonary dysplasia. J Perinatol. 2018;38(9):1258–1265.
  • Patel AL, Johnson TJ, Robin B, et al. Influence of own mother’s milk on bronchopulmonary dysplasia and costs. Arch Dis Child Fetal Neonatal Ed. 2017;102(3):F256–F61.
  • Klinger G, Sirota L, Lusky A, et al. Israel Neonatal Network. Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay. J Perinatol. 2006;26(10):640–644.
  • Smith VC, Zupancic JA, McCormick MC, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004;144(6):799–803.
  • Mowitz ME, Ayyagari R, Gao W, et al. Health care burden of bronchopulmonary dysplasia among extremely preterm infants. Front Pediatr. 2019;7:510.
  • Lapcharoensap W, Bennett MV, Xu X, et al. Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life. J Perinatol. 2020;40(1):130–137.
  • Zupancic JAF. Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes. D, A systematic review of costs associated with preterm birth. In: Behrman RE, Butler AS, editors. Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press (US); 2007;688-724.
  • Iyengar A, Davis JM. Drug therapy for the prevention and treatment of bronchopulmonary dysplasia. Front Pharmacol. 2015;6:12.
  • Latini G, De Felice C, Giannuzzi R, et al. Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants. Early Hum Dev. 2013;89(Suppl1):S69–S73.
  • Ryan RM, Keller RL, Poindexter BB, et al. PROP Investigators. Respiratory medications in infants <29 weeks during the first year postdischarge: the prematurity and respiratory outcomes program (PROP) consortium. J Pediatr. 2019;208:148–155.
  • Poindexter BB, Feng R, Schmidt B, et al. Prematurity and Respiratory Outcomes Program. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12(12):1822–1830.
  • Stoll BJ, Hansen NI, Bell EF, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443–456.
  • Lapcharoensap W, Gage SC, Kan P, et al. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. JAMA Pediatr. 2015;169(2):e143676.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.